Pharmacokinetics and pharmacodynamics of fenoldopam mesylate for blood pressure control in pediatric patients
2008

Using Fenoldopam to Control Blood Pressure in Children

Sample size: 76 publication Evidence: moderate

Author Information

Author(s): Gregory B Hammer, Susan T Verghese, David R Drover, Myron Yaster, Joseph R Tobin

Primary Institution: Stanford University School of Medicine

Hypothesis

What are the pharmacokinetic and pharmacodynamic characteristics of fenoldopam in pediatric patients?

Conclusion

Fenoldopam is effective for controlling blood pressure in children during surgery, with a higher effective dose range than in adults.

Supporting Evidence

  • Fenoldopam at doses of 0.8 and 3.2 mcg/kg/min significantly reduced blood pressure.
  • The effective dose range for children is 0.8–1.2 mcg/kg/min.
  • Side effects were minimal and occurred in a minority of patients.

Takeaway

Fenoldopam helps lower blood pressure in kids during surgery, and they need a higher dose than adults to get the same effect.

Methodology

A randomized, multicenter, placebo-controlled trial with 77 children aged 3 weeks to 12 years undergoing surgery.

Limitations

The anesthetic technique varied, newborns and older adolescents were excluded, and the study did not assess long-term effects.

Participant Demographics

Majority were males (56%) and Caucasians (65%), mean age was 51.9 months.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2253-8-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication